A report of a new late toxic effect of lenvatinib
Sign Up to like & getrecommendations! Published in 2020 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000000690
Abstract: [4] of normal tissues. Hescot et al first reported on two To the Editor: Hepatocellular carcinoma (HCC) is the [1] third most lethal malignancy globally. Besides sorafenib, patients who developed irreversible pancreatic atrophy [5] lenvatinib… read more here.
Keywords: report new; new late; toxic effect; late toxic ... See more keywords
Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer"
DOI: 10.7150/jca.50292
Abstract: Gallbladder cancer (GBC) is characterized by poor prognosis, early metastasis, and high recurrence rates, which seriously threaten human health. The effect of lenvatinib, a widely used drug in anti-hepatocellular carcinoma in China, on GBC progress,… read more here.
Keywords: lenvatinib; gbc; gallbladder cancer; cell ... See more keywords